NC Testing in LC & POTS

Recruiting N/A Interventional Study
Postural Orthostatic Tachycardia Syndrome Post Acute Sequelae of SARS CoV 2 Infection
Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 60
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
University of Calgary · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Patients with Postural Orthostatic Tachycardia Syndrome (POTS) and Post-Acute Sequelae of COVID (PASC, or "Long COVID") experience cognitive dysfunction. The investigators will test the hypothesis that 999 mL of IV saline will improve cognitive function in patients with POTS and Long COVID compared to placebo (50 mL of saline).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with diagnosis of Long COVID * SARS-COV2 test positive * Symptoms \> 12 weeks post COVID * Subjective complaint of 'brain fog" or cognitive dysfunction * Patients with diagnosis of Postural Orthostatic Syndrome (POTS) from the Calgary Autonomic Investigation and Manag…
Contacts

Satish R Raj, MD MSCI

(403)210-6152

autonomic.research@ucalgary.ca

CONTACT

Rasha Hamzeh, RN

autonomic.research@ucalgary.ca

CONTACT